NanoPharmaceuticals LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- NanoPharmaceuticals LLC
- Target Recruit Count
- 34
- Registration Number
- NCT05226494
- Locations
- 🇺🇸
Smilow Cancer Hospital, New Haven, Connecticut, United States
News
No news found